Finance

Lists
BBNX:NASDAQ
Beta Bionics Inc
US$ १७.८६
+१.३०%
(+०.२३) 1D
US$ १७.८६
०.००% (०.००)
After hours
Closed: अक्टोबर १२, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BBNX...
Open
US$ १७.९४
High
US$ १८.५६
Low
US$ १७.७१
Mkt. cap
९४.०० करोड
Avg. vol.
१३.३६ लाख
Volume
८.२१ लाख
52-wk high
US$ ३२.७१
52-wk low
US$ ८.८०
EPS
-US$ १.६५
Shares outstanding
५.२६ करोड
No. of employees
४२२
Open
US$ १७.९४
High
US$ १८.५६
Low
US$ १७.७१
Mkt. cap
९४.०० करोड
Avg. vol.
१३.३६ लाख
Volume
८.२१ लाख
52-wk high
US$ ३२.७१
52-wk low
US$ ८.८०
EPS
-US$ १.६५
Shares outstanding
५.२६ करोड
No. of employees
४२२
News stories
From web sources and news partners
About Beta Bionics Inc
CEO-
Employees४२२
Founded२०१५
Headquartersइरविन, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websitebetabionics.com
Analyst ratings
Based on 15 analysts giving stock ratings to BBNX in the past 3 months
Buy
Buy
11
Hold
4
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for BBNX in the last 3 months.
Highest
Current US$ १७.८६
US$ ३०.४० (+७०.२१%)
Average
US$ २४.१७ (+३५.३३%)
Lowest
US$ १६.०० (-१०.४१%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Toomey
Jefferies
Buy
Initiated
US$ ३०.००
+६८%
10/12/2026
Christopher Pasquale
Barclays
Buy
Initiated
US$ ३०.००
+६८%
10/06/2026
Unknown Analyst
Barclays
Buy
Initiated
US$ ३०.००
+६८%
10/06/2026
Richard Newitter
Truist Financial
Buy
Reiterated
US$ २८.००
+५६.८%
09/24/2026
Larry Biegelsen
Wells Fargo
Buy
Initiated
US$ २८.००
+५६.८%
09/23/2026
Frank Takkinen
Lake Street
Buy
Reiterated
US$ २५.००
+४०%
09/22/2026
Mike Kratky
Leerink Partners
Buy
Reiterated
US$ २७.००
+५१.२%
09/17/2026
Jonathan Block
Stifel Nicolaus
Buy
Maintained
US$ २२.००
+२३.२%
09/15/2026
Jeff Johnson
Robert W. Baird
Hold
Maintained
US$ १६.००
-१०.४%
09/15/2026
Patrick Wood
UBS
Buy
Maintained
US$ २५.००
+४०%
09/15/2026
Travis Steed
Bank of America Securities
Hold
Reiterated
US$ २०.००
+१२%
09/14/2026
Mathew Blackman
TD Cowen
Hold
Maintained
US$ १८.००
+०.८%
09/14/2026
Steven Lichtman
William Blair
Hold
Maintained
-
-
09/14/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Reiterated
US$ ३०.४०
+७०.२%
07/30/2026
Matthew O'Brien
Piper Sandler
Buy
Reiterated
US$ २०.००
+१२%
07/30/2026
Danielle Antalffy
UBS
Buy
Initiated
US$ २२.००
+२३.२%
07/28/2026
David Roman
Goldman Sachs
Buy
Reiterated
US$ १९.००
+६.४%
07/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२.७३ करोड
३.२१ करोड
२.७६ करोड
३.२० करोड
Cost of goods sold
१.२१ करोड
१.३२ करोड
१.१२ करोड
१.३१ करोड
Cost of revenue
१.२१ करोड
१.३२ करोड
१.१२ करोड
१.३१ करोड
Research and development expenses
८१.९५ लाख
१.०१ करोड
१.०४ करोड
१.०२ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.४० करोड
२.४९ करोड
३.०४ करोड
३.४२ करोड
Operating expense
३.२२ करोड
३.५१ करोड
४.०७ करोड
४.४५ करोड
Total operating expenses
४.४३ करोड
४.८२ करोड
५.१९ करोड
५.७६ करोड
Operating income
-१.७० करोड
-१.६१ करोड
-२.४३ करोड
-२.५६ करोड
Other non operating income
१.०० हजार
-
-
-२.०० हजार
EBT including unusual items
-१.४२ करोड
-१.३५ करोड
-२.१९ करोड
-२.३४ करोड
EBT excluding unusual items
-१.४२ करोड
-१.३५ करोड
-२.१९ करोड
-२.३४ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-१.४२ करोड
-१.३५ करोड
-२.१९ करोड
-२.३४ करोड
Net profit margin
-५२.१४%
-४१.९२%
-७९.२५%
-७३.१०%
Earnings per share
-०.३३
-०.१९
-०.३६
-०.३६
Interest and investment income
२८.३३ लाख
२६.५८ लाख
२३.७६ लाख
२१.७७ लाख
Interest expense
-
-
-
-
Net interest expenses
२८.३३ लाख
२६.५८ लाख
२३.७६ लाख
२१.७७ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.६७ करोड
-१.५६ करोड
-२.३७ करोड
-२.४९ करोड
Gain or loss from assets sale
-
३१.०० हजार
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू